Anvisa aprova primeiro genérico de semaglutida no Brasil

from Saúde em Foco - Luis Fernando Correia · host CBN

A Anvisa aprovou o primeiro genérico de semaglutida do Brasil. O médico Luis Fernando Correia explicou que a farmacêutica EMS desenvolveu uma versão sintética da mesma molécula, produzida por síntese química, ou seja, combinando substâncias no laboratório, sem célula viva. Learn more about your ad choices. Visit megaphone.fm/adchoices

Episode metadata supplied by the publisher feed · Published Aug 18, 2026

Embed this episode

Attribution link and audio player

NOW PLAYING

Anvisa aprova primeiro genérico de semaglutida no Brasil

0:00 5:54

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Saúde em Foco - Luis Fernando Correia?

This episode is 5 minutes long.

When was this Saúde em Foco - Luis Fernando Correia episode published?

This episode was published on August 18, 2026.

Can I download this Saúde em Foco - Luis Fernando Correia episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!